Wired to run: Exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'

Journal of Experimental Biology

Volumn 215, Issue 8, 2012, Pages 1331-1336

  Raichlen, David A ^a   Foster, Adam D ^a   Gerdeman, Gregory L ^b   Seillier, Alexandre ^c   Giuffrida, Andrea ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b ECKERD COLLEGE   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

2 AG; AEA; Endogenous cannabinoid; Exercise; Homo; Locomotion; Positive affect; Running; Walking

Indexed keywords

ENDOCANNABINOID;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; CLINICAL TRIAL; DOG; ENDURANCE; EXERCISE; FERRET; HUMAN; METABOLISM; PHYSIOLOGY; RUNNING; SIGNAL TRANSDUCTION;

ANIMALS; DOGS; ENDOCANNABINOIDS; EXERCISE; FERRETS; HUMANS; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; RUNNING; SIGNAL TRANSDUCTION;

EID: 84860149976     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.063677     Document Type: Article

References (56)

1. Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K. et al. (2007). Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci. 10, 870-879.
2. Alexander, R. M. and Jayes, A. S. (1983). A dynamic similarity hypothesis for the gaits of quadrupedal mammals. J. Zool. Lond. 201, 135-152.
3. Bramble, D. M. and Lieberman, D. E. (2004). Endurance running and the evolution of Homo. Nature 432, 345-352.
4. Bryan, A., Hutchinson, K. E., Seals, D. R. and Allen, D. L. (2007). A transdisciplinary model integrating genetic, physiological, and psychological correlates of voluntary exercise. Health Psychol. 26, 30-39.
5. Carrier, D. R. (1984). The energetic paradox of human running and hominid evolution. Curr. Anthropol. 25, 483-495.
6. Chaperon, F. and Thiebot, M. H. (1999). Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 13, 243-281.
7. Cheer, J. F., Wassum, K. M., Sombers, L. A., Heien, M. L. A. V., Ariansen, J. L., Aragona, B. J., Phillips, P. E. M. and Wightman, R. M. (2007). Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci. 27, 791-795.
8. Cotes, J. E. and Meade, F. (1960). The energy expenditure and mechanical energy demand in walking. Ergonomics 3, 97-120.
9. Diaz, J. (1997). How Drugs Influence Behavior: a Neurobehavioral Approach. Saddle River, NJ: Prentice Hall.
10. Dietrich, A. and McDaniel, W. F. (2004). Endocannabinoids and exercise. Br. J. Sports Med. 38, 536-541.
11. Egloff, B. (1998). The independence of positive and negative affect depends on the affect measure. Pers. Individ. Diff. 25, 1101-1109.
12. Ekkekakis, P., Hall, E. E. and Petruzzello, S. J. (2004). Practical markers of the transition from aerobic to anaerobic metabolism during exercise: rationale and a case for affect-based exercise prescription. Prev. Med. 38, 149-159.
13. Ekkekakis, P., Hall, E. E. and Petruzzello, S. J. (2005). Variation and homogeneity in affective responses to physical activity of varying intensities: an alternative perspective on dose-response based on evolutionary considerations. J. Sports Sci. 23, 477-500.
14. Gerdeman, G. L. (2008). Endocannabinoids at the synapse - retrograde signaling and presynaptic plasiticity in the brain. In Cannabinoids and the Brain (ed. A. Kofalvi), pp. 203-236. New York: Springer-Verlag.
15. Gerdeman, G. L., Partridge, J. G., Lupica, C. R. and Lovinger, D. M. (2003). It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 26, 184-192.
16. Glaser, S. T., Gatley, S. J. and Gifford, A. N. (2006). Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. J. Pharmacol. Exp. Ther. 316, 1088-1097.
17. Hardison, A., Weintraub, S. T. and Giuffrida, A. (2006). Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations. Prostaglandins Other Lipid Mediat. 81, 106-112.
18. Hoffman, M. D. and Hoffman, D. R. (2007). Pain perception and mood? A review of the evidence related to healthy and chronic pain subjects. Curr. Pain Headache Rep. 11, 93-97.
19. Hohmann, A. G. and Suplita, R. L. (2006). Endocannabinoid mechanisms of pain modulation. AAPS Journal 8, E693-E708.
20. Hohmann, A. G., Tsou, K. and Walker, J. M. (1999). Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. J. Neurophysiol. 81, 575-583.
21. Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderha, T. W., Lai, J., Porreca, F., Makriyannis, A. et al. (2003). Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition not present in CNS. Proc. Natl. Acad. Sci. USA 100, 10529-10533.
22. Jenkins, F. A. J. (1971). Limb posture and locomotion in the Virginia opossum (Didelphis marsupialis) and in other non-cursorial mammals. J. Zool. 165, 303-315.
23. Johnson, K. A., Muir, O., NIcoll, R. G. and Roush, J. K. (2000). Asymmetric adaptive modeling of central tarsal bones in racing greyhounds. Bone 27, 257-263.
24. Justinova, Z., Solinas, M., Tanda, G., Redhi, G. H. and Goldberg, S. R. (2005). The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. J. Neurosci. 25, 5645-5650.
25. Justinova, Z., Yasar, S., Redhi, G. H. and Goldberg, S. R. (2011). The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys. J. Neurosci. 31, 7043-7048.
26. Keeney, B. K., Raichlen, D. A., Meek, T. H., Wijeratne, R. S., Middleton, K. M., Gerdeman, G. L. and Garland, T. J. (2008). Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behavior. Behav. Pharmacol. 19, 812-820.
27. King, C. M. and Powell, R. A. (2007). The Natural History of Weasels and Stoats. New York: Oxford University Press.
28. Koltyn, K. F. (2002). Exercise-induced hypoalgesia and intensity of exercise. Sports Med. 32, 477-487.
29. Kwan, B. M. and Bryan, A. (2010). In-task and post-task affective response to exercise: translating exercise intentions into behaviour. Br. J. Health Psychol. 15, 115-131.
30. Lupica, C. R. and Riegel, A. C. (2005). Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 48, 1105-1116.
31. Mahler, S. V., Smith, K. S. and Berridge, K. C. (2007). Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumebens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 32, 2267-2278.
32. Malina, R. M. and Little, B. B. (2008). Physical activity: the present in the context of the past. Am. J. Hum. Biol. 20, 373-391.
33. Margaria, R., Cerretelli, P., Aghemo, P. and Sassi, G. (1963). Energy cost of running. J. Appl. Physiol. 18, 367-370.
34. Meng, I. D., Manning, B. H., Martin, W. J. and Fields, H. L. (1998). An analgesia circuit activated by cannabinoids. Nature 395, 381-383.
35. Menier, D. R. and Pugh, L. G. C. E. (1968). The relation of oxygen intake and velocity of walking and running in competition walkers. J. Physiol. 197, 717-721.
36. Minetti, A. E. (2001). Walking on other planets. Nature 409, 467-469.
37. Mossholder, K. W., Kemery, E. R., Harris, S. G., Armenakis, A. A. and McGrath, R. (1994). Confounding constructs and levels of constructs in affectivity measurement: an empirical investigation. Educ. Psychol. Meas. 54, 336-349.
38. Ogles, B. M. and Masters, K. S. (2003). A typology of marathon runners based on cluster analysis of motivations. J. Sport Behav. 26, 69-85.
39. Panksepp, J., Knutson, B. and Brurgdorf, J. (2002). The role of brain emotional systems in additions: a neuro-evolutionary perspective and new 'self-report' animal model. Addiction 97, 459-469.
40. Pinchbeck, G. L., Clegg, P. D., Proudman, C. J., Stirk, A., Morgan, K. L. and French, N. P. (2004). Horse injuries and racing practices in National Hunt racehorses in the UK: the results of a prospective cohort study. Vet. J. 167, 45-52.
41. Piomelli, D. (2003). The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4, 873-884.
42. Prole, J. H. B. (1976). A survey of racing injuries in the greyhound. J. Small Anim. Pract. 17, 207-218.
43. Reed, J. and Ones, D. S. (2006). The effect of acute aerobic exercise on positive activated affect: a meta-analysis. Psychol. Sport Exerc. 7, 477-514.
44. Russell, J. A. and Carroll, J. M. (1999). On the bipolarity of positive and negative affect. Psychol. Bull. 125, 3-30.
45. Sachs, M. and Pargman, D. (1979). Running addiction: a depth view. J. Sports Behav. 2, 143-155.
46. Schneider, M., Dunn, A. and Cooper, D. (2009). Affect, exercise, and physical activity among healthy adolescents. J. Sport Exerc. Psychol. 31, 706-723.
47. Scully, D., Kremer, J., Meade, M. M., Gradam, R. and Dudgeon, K. (1998). Physical exercise and psychological well being: a critical review. Br. J. Sports Med. 32, 111-120.
48. Sher, L. (1998). The endogenous euphoric reward system that reinforces physical training: a mechanism for mankind's survival. Med. Hypotheses 51, 449-450.
49. Solinas, M., Justinova, Z., Goldberg, S. R. and Tanda, T. (2006). Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J. Neurochem. 98, 408-419.
50. Sparling, P. B., Giuffrida, A., Piomelli, D., Rosskopf, L. and Dietrich, A. (2003). Exercise activates the endocannabinoid system. NeuroReport 14, 2209-2211.
51. Tanaka, H., Monahan, K. D. and Seals, D. R. (2001). Age-predicted maximal heart rate revisited. J. Am. Coll. Cardiol. 37, 153-156.
52. Vaughn, L. K., Denning, G., Stuhr, K. L., Wit, H., Hill, M. N. and Hillard, C. J. (2010). Endocannabinoid signalling: has it got rhythm? Br. J. Pharmacol. 160, 530-543.
53. Watson, D., Clark, L. A. and Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 54, 1063-1070.
54. Williams, D. M., Dunsiger, S., Ciccolo, J. T., Lewis, B. A., Albrecht, A. E. and Marcus, B. H. (2008). Acute affective response to a moderate-intensity exercise stimulus predicts physical activity participation 6 and 12 months later. Psychol. Sport Exerc. 9, 231-245.
55. Willoughby, K. A., Moore, S. F., Martin, B. R. and Ellis, E. F. (1997). The biodisposition and metabolism of anandamide in mice. J. Pharmacol. Exp. Ther. 282, 243-247.
56. Zoerner, A. A., Gutzki, F. M., Suchy, M. T., Beckmann, B., Engeli, S., Jordan, J. and Tsikas, D. (2009). Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma. J. Chromatogr. B. Biomed. Appl. 877, 2909-2923.